Norges Bank’s Metagenomi Therapeutics MGX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGX
Norges Bank's MGX Position: Q4 2025 in Review
Norges Bank sold out of Metagenomi Therapeutics (MGX) in Q4 2025, closing a stake of 252,310 shares — an estimated $598K sold.
Norges Bank first reported a position in MGX in Q1 2024 and held it in 7 quarters. The position peaked at $1.47M in Q2 2024. 56 funds tracked by Wall St. Rank hold MGX as of Q4 2025.
- Norges Bank reported no remaining Metagenomi Therapeutics position as of Q4 2025 after selling out during the quarter.
- Norges Bank sold 252,310 Metagenomi Therapeutics shares in Q4 2025, an estimated $598K.
- Norges Bank first reported a position in Metagenomi Therapeutics in Q1 2024 and held it in 7 quarters.
- Norges Bank's Metagenomi Therapeutics position peaked at $1.47M in Q2 2024.
- 56 funds tracked by Wall St. Rank held Metagenomi Therapeutics as of Q4 2025.
Based on Norges Bank's 13F filing for Q4 2025, filed 10 Feb 2026.